Divis Laboratories Ltd (DIVISLAB) - Financial and Strategic SWOT Analysis Review

Divis Laboratories Ltd (DIVISLAB) - Financial and Strategic SWOT Analysis Review

  • Products Id :- GDPH113654FSA
  • |
  • Pages: 40
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Divi's Laboratories Ltd (DIVISLAB)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Divi's Laboratories Ltd (Divi's) is a pharmaceutical company which manufactures a broad range Active Pharmaceutical Ingredients (APIs) and intermediates. The product portfolio of the company includes generic APIs, nutraceuticals, custom synthesis of APIs, intermediates and specialty ingredients. The company operates across several countries in Europe and America. It operates manufacturing and research and development units in Hyderabad and Visakhapatnam, India. Divi's is headquartered in Hyderabad, Telangana, India.

Divi's Laboratories Ltd Key Recent Developments

May 16,2018: Divi's Laboratories: US-FDA Inspection of Unit -I at Choutuppal, Telangana State

Jan 27,2018: Divi's Labs earns Profit after Tax of Rs.225 crores in Q3/FY18

Nov 18,2017: EIR From US-FDA Received for Unit-II at Visakhapatnam

Nov 14,2017: Divi's Laboratories: Update on lifting of Import Alert 66-40 by US-FDA

Nov 02,2017: Divi's Laboratories: Update by USFDA on Unit-II at Visakhapatnam

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Divi's Laboratories Ltd-Key Facts 5

Divi's Laboratories Ltd-Key Employees 6

Divi's Laboratories Ltd-Key Employee Biographies 7

Divi's Laboratories Ltd-Major Products and Services 8

Divi's Laboratories Ltd-History 9

Divi's Laboratories Ltd-Company Statement 10

Divi's Laboratories Ltd-Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Section 2-Company Analysis 12

Company Overview 12

Divi's Laboratories Ltd-Business Description 13

Divi's Laboratories Ltd-Corporate Strategy 14

Divi's Laboratories Ltd-SWOT Analysis 15

SWOT Analysis-Overview 15

Divi's Laboratories Ltd-Strengths 15

Divi's Laboratories Ltd-Weaknesses 16

Divi's Laboratories Ltd-Opportunities 17

Divi's Laboratories Ltd-Threats 18

Divi's Laboratories Ltd-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 24

Financial Performance 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Recent Developments 26

May 16, 2018: Divi's Laboratories: US-FDA Inspection of Unit -I at Choutuppal, Telangana State 26

Nov 18, 2017: EIR From US-FDA Received for Unit-II at Visakhapatnam 27

Nov 14, 2017: Divi's Laboratories: Update on lifting of Import Alert 66-40 by US-FDA 28

Nov 02, 2017: Divis Laboratories: US-FDA Inspection of Unit -II 29

Sep 20, 2017: Divi's Laboratories: Update on USFDA for Unit-II at Visakhapatnam 30

Jul 22, 2017: Divi's Labs earns a total income of Rs. 851 crores for Q1 of FY18 31

Jul 22, 2017: Divi's Laboratories : Outcome of Board meeting-Appointment of Director 32

Jul 10, 2017: Divi's Laboratories: Update on Unit-II at Visakhapatnam 33

Mar 22, 2017: Divis Laboratories Provides an Update on FDA Import Alert 34

Mar 22, 2017: Divis Laboratories Provides an Update on FDA Import Alert 35

Section 5-Appendix 36

Methodology 36

Ratio Definitions 36

About GlobalData 40

Contact Us 40

Disclaimer 40

List of Figures

Divi's Laboratories Ltd, Performance Chart (2014-2018) 24

Divi's Laboratories Ltd, Ratio Charts 25

List of Tables

Divi's Laboratories Ltd, Key Facts 5

Divi's Laboratories Ltd, Key Employees 6

Divi's Laboratories Ltd, Key Employee Biographies 7

Divi's Laboratories Ltd, Major Products and Services 8

Divi's Laboratories Ltd, History 9

Divi's Laboratories Ltd, Subsidiaries 11

Divi's Laboratories Ltd, Key Competitors 19

Divi's Laboratories Ltd, Ratios based on current share price 20

Divi's Laboratories Ltd, Annual Ratios 21

Divi's Laboratories Ltd, Annual Ratios (Cont...1) 22

Divi's Laboratories Ltd, Annual Ratios (Cont...2) 23

Currency Codes 36

Capital Market Ratios 36

Equity Ratios 37

Profitability Ratios 37

Cost Ratios 38

Liquidity Ratios 38

Leverage Ratios 39

Efficiency Ratios 39

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Piramal Enterprises Ltd

Jubilant Life Sciences Ltd

Hikal Ltd

Granules India Ltd

Dishman Pharmaceuticals and Chemicals Ltd

Biocon Ltd

Divi's Laboratories Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8916
Site License
USD 250 INR 17833
Corporate User License
USD 375 INR 26749



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com